Jay R. Luly, President and CEO at ENANTA PHARMACEUTICALS INC (ENTA), sold 10,000 shares at $37.61 ($385K) on 2014-03-10, disclosed to the SEC on 2014-03-12.
Scheduled sale ($385k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.61 | 3,700 | $139K | 36.2% |
| 2 | $38.77 | 3,615 | $140K | 36.4% |
| 3 | $39.32 | 2,685 | $106K | 27.4% |
| Total | $38.49 avg | 10,000 | $385K | 100% |
| Filing → |
| ENTA | SELL | 2024-12-10 | $41K | — | Filing → |
| ENTA | SELL | 2023-12-06 | $139K | — | Filing → |
| ENTA | SELL | 2023-03-14 | $2.5M | — | Filing → |